Breast cancer screening and cancer prognosis in patients with Alzheimer’s disease and related dementias
JNCI Cancer Spectrum · 2026
DOI: 10.1093/jncics/pkag019 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Yushi Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Alzheimer Disease, Early Detection of Cancer, Dementia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, CDC HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Breast cancer screening is crucial for early detection and improved survival in Alzheimer’s Disease and Related Dementias (ADRD) patients, but real-world evidence of its effects on survival and prognosis remains insufficient.
Methods
We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results-Medicare data (1999 to 2019) to analyze the impact of breast cancer screening on prognosis (ie cancer stage) and survival in ADRD women with breast cancer diagnosed ≥ 67 years. Logistic and Cox regression models were employed to assess the relationship between screening and risk of advanced stage at diagnosis, and length of survival, adjusted for relevant covariates (e.x. marital status, comorbidities, age at screening).
Results
The cohort included 8,739 ADRD patients with breast cancer, with 4,483 completed at least one screening between their ADRD and first breast cancer diagnosis. The cohort completed screening had significant lower rates of advanced-stage diagnosis (22.2% vs 42.6%) and longer survival (65.9 vs 45.7 months) compared to the cohort without any screening history. Unscreened patients had 2.7 times higher odds of advanced-stage diagnosis, and 2 times higher hazard of death than patients with at least one screening completed before breast cancer diagnosis. Effects of comorbidities, age, and race were significant on both diagnosis stage and survival in breast cancer patients.
Conclusion
Our study demonstrated the benefit of screening in early diagnosis and longer survival in ADRD patients with breast cancer, which advocates for an expansion of current breast cancer screening recommendations to more effectively guide cancer care for ADRD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, United States.
- Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
- Department of Biostatistics, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, FL, United States.
- Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
- Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, United States.
- Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, United States.
ORCID-Profile: Yushi Huang, Jessica Y Islam, Muxuan Liang, Thomas J George, Jiang Bian, Yi Guo
Förderung
- NIH HHS
- CDC HHS
Zitieren
APA
Huang, Y., Li, Y., Lou, X., Islam, J. Y., Liang, M., George, T. J., Bian, J., & Guo, Y. (2026). Breast cancer screening and cancer prognosis in patients with Alzheimer’s disease and related dementias. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag019
Vancouver
Huang Y, Li Y, Lou X, Islam JY, Liang M, George TJ, et al. Breast cancer screening and cancer prognosis in patients with Alzheimer’s disease and related dementias. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag019
BibTeX
@article{Huang2026,
author = {Huang, Yushi and Li, Yongqiu and Lou, Xiwei and Islam, Jessica Y and Liang, Muxuan and George, Thomas J and Bian, Jiang and Guo, Yi},
title = {Breast cancer screening and cancer prognosis in patients with Alzheimer’s disease and related dementias},
journal = {JNCI Cancer Spectrum},
year = {2026},
doi = {10.1093/jncics/pkag019}
}
EUVIMED